DRW Holdings »

Candel Therapeutics shares owned by DRW Holdings

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by DRW Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $147k 14k 10.30

More positions owned by DRW Holdings

iShares Russell 2000 Index Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Asml Hldg Nv N Y Registry Shs Call Option (ASML)
Tesla Motors Call Option (TSLA)
Ishares Msci Brazil Etf Call Option (EWZ)
Vestas Put Option (VWSYF)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)
Taiwan Semiconductor Mfg Call Option (TSM)
Ershares Private-public Cros Fund (XOVR)

View all positions for DRW Holdings

Top funds holding Candel Therapeutics

FMR
Rtw Investments
BlackRock
Acorn Capital Advisors
Portolan Capital Management
Saturn V Capital Management
Vanguard Capital Management
Geode Capital Management
Millennium Management
State Street Corporation
Halter Ferguson Financial
Northern Trust
Kennedy Capital Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Candel Therapeutics